N-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide

C19H19F3N4O2 — CID 75472749

IUPACN-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide
SMILESO=C1CCCc2cc(NC(=O)C3CCn4c(cnc4C(F)(F)F)C3)ccc2N1
InChIInChI=1S/C19H19F3N4O2/c20-19(21,22)18-23-10-14-9-12(6-7-26(14)18)17(28)24-13-4-5-15-11(8-13)2-1-3-16(27)25-15/h4-5,8,10,12H,1-3,6-7,9H2,(H,24,28)(H,25,27)
InChIKeyFLURYTJPJCBUOA-UHFFFAOYSA-N
MW392.38 g/mol
LogP3.38
Rot. Bonds2

About N-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide

N-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide (PubChem CID 75472749) has the molecular formula C19H19F3N4O2 and a molecular weight of 392.38 g/mol. Its IUPAC name is N-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide.

Molecular Properties

Compound NameN-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide
PubChem CID75472749
Molecular FormulaC19H19F3N4O2
Molecular Weight392.38 g/mol
Exact Mass392.15
IUPAC NameN-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide
SMILESO=C1CCCc2cc(NC(=O)C3CCn4c(cnc4C(F)(F)F)C3)ccc2N1
InChIInChI=1S/C19H19F3N4O2/c20-19(21,22)18-23-10-14-9-12(6-7-26(14)18)17(28)24-13-4-5-15-11(8-13)2-1-3-16(27)25-15/h4-5,8,10,12H,1-3,6-7,9H2,(H,24,28)(H,25,27)
InChIKeyFLURYTJPJCBUOA-UHFFFAOYSA-N
XLogP3.38
TPSA76.02 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds2
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500392.38
LogP ≤ 53.38
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze N-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide?
The IUPAC name of N-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide (CID 75472749) is N-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide.
What is the SMILES notation for N-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide?
The canonical SMILES for N-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide is O=C1CCCc2cc(NC(=O)C3CCn4c(cnc4C(F)(F)F)C3)ccc2N1.
What is the InChIKey of N-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide?
The InChIKey is FLURYTJPJCBUOA-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H19F3N4O2/c20-19(21,22)18-23-10-14-9-12(6-7-26(14)18)17(28)24-13-4-5-15-11(8-13)2-1-3-16(27)25-15/h4-5,8,10,12H,1-3,6-7,9H2,(H,24,28)(H,25,27).
What are the key properties of N-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide?
N-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide has a molecular weight of 392.38 g/mol, XLogP of 3.38, 2 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-oxo-1,3,4,5-tetrahydro-1-benzazepin-7-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-7-carboxamide is sourced from PubChem (CID 75472749), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).